| Pooja Garg, MD | |
|
6280 W Sample Rd Ste 202, Coral Springs, FL 33067 | |
| (561) 322-3588 | |
| (561) 322-3589 |
| Full Name | Pooja Garg |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 6280 W Sample Rd Ste 202, Coral Springs, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932496346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME135587 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bedotto Wallace Clewner And Kelly, Md, Pa | 0446353478 | 3 |
| S Daniel Salama Md Pa | 4284635152 | 3 |
| South Florida Surgical Specialists Llc | 5799881660 | 83 |
| Weston Laser And Vision Institute, Inc | 9234282161 | 6 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Entity Name | S Daniel Salama Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407944861 PECOS PAC ID: 4284635152 Enrollment ID: O20070119000008 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Entity Name | Bedotto Wallace Clewner & Kelly, Md, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285654723 PECOS PAC ID: 0446353478 Enrollment ID: O20070313000379 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Entity Name | South Florida Surgical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952409963 PECOS PAC ID: 5799881660 Enrollment ID: O20070509000683 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Entity Name | Weston Laser & Vision Institute, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568642676 PECOS PAC ID: 9234282161 Enrollment ID: O20090724000538 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Entity Name | Maged S. Habib, M.d. P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578735379 PECOS PAC ID: 9931317666 Enrollment ID: O20120703000140 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pooja Garg, MD 6280 W Sample Rd Ste 202, Coral Springs, FL 33067-3173 Ph: (561) 322-3588 | Pooja Garg, MD 6280 W Sample Rd Ste 202, Coral Springs, FL 33067 Ph: (561) 322-3588 |
News Archive
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.
Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
› Verified 8 days ago
Dr. Leon Albert Bynoe, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1881 N. University Dr., Ste. 112, Coral Springs, FL 33071 Phone: 954-755-4633 Fax: 954-755-4637 | |
Dr. Neerav Neel Lamba, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 6280 W Sample Rd Ste 202, Coral Springs, FL 33067 Phone: 561-322-3588 Fax: 754-812-5993 | |
Cindy Hernandez, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8130 Royal Palm Blvd, Ste 101, Coral Springs, FL 33065 Phone: 954-340-1500 Fax: 954-753-8309 | |
Dr. Norman Michael Kline, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1801 N University Dr, Suite 102, Coral Springs, FL 33071 Phone: 954-344-0999 Fax: 954-344-7929 | |
Dr. Donald R Woods, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7886 West Sample Rd, Coral Springs, FL 33065 Phone: 954-752-6465 Fax: 954-752-6591 | |
Dr. Henry E. Glick, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3100 Coral Hills Dr, Suite #206, Coral Springs, FL 33065 Phone: 954-575-4711 Fax: 954-575-4722 | |
Dr. Robert Dale Cole, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4818 Nw 58th Ave, Coral Springs, FL 33067 Phone: 903-654-0653 |